Skip to main content

Table 3 Candidate BM association with steroid HR and HER2 status in IBC

From: Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ

Candidate BM

Clinical marker

OR

95%

P-value

IGF-IR

ER

1.44

0.92-2.26

0.11

PR

2.09

1.29-3.38

0.003 a

HER2

0.94

0.56-1.56

0.81

Rap1

ER

1.85

1.09-3.17

0.024

PR

1.86

1.14-3.05

0.014

HER2

1.17

0.73-1.89

0.81

Vav2

ER

1.09

0.71-1.67

0.69

PR

1.17

0.78-1.76

0.46

HER2

0.96

0.58-1.60

0.88

  1. aassociations between markers found to be significant are in bold.
Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us